Cell & Gene: The Podcast
Cell & Gene: The Podcast
Erin Harris
Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells
19 minutes Posted Dec 22, 2021 at 9:00 am.
0:00
19:11
Download MP3
Show notes

We love to hear from our listeners. Send us a message.

Vor Biopharma's CEO Dr. Robert Ang explains the company's lead engineered hematopoietic cell (eHSC) product candidate, genome engineering of HSCs, and the cell manufacturing process needed to leverage genome engineering technologies for the cells they're creating.